FRASCAROLI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 390
EU - Europa 191
AS - Asia 102
AF - Africa 4
SA - Sud America 2
Totale 689
Nazione #
US - Stati Uniti d'America 388
IT - Italia 69
CN - Cina 61
IE - Irlanda 39
AT - Austria 21
SG - Singapore 21
SE - Svezia 19
FR - Francia 16
VN - Vietnam 12
FI - Finlandia 5
GB - Regno Unito 4
SN - Senegal 4
DE - Germania 3
DK - Danimarca 3
PL - Polonia 3
TW - Taiwan 3
UA - Ucraina 3
BE - Belgio 2
BR - Brasile 2
HK - Hong Kong 2
NL - Olanda 2
CA - Canada 1
GR - Grecia 1
ID - Indonesia 1
KR - Corea 1
MX - Messico 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 689
Città #
Chandler 86
Torino 42
Dublin 39
Beijing 32
Ashburn 27
Houston 24
Fairfield 22
Ann Arbor 21
Vienna 21
Cambridge 17
Singapore 15
Medford 14
Seattle 14
Villeurbanne 13
Nyköping 11
Wilmington 10
Princeton 9
Woodbridge 9
Dearborn 8
Dong Ket 6
Jacksonville 6
Turin 6
Hefei 5
Nanjing 5
Napoli 4
Pisa 4
Redwood City 4
Nanchang 3
Nashville 3
Santa Clara 3
Taipei 3
Xian 3
Brussels 2
Copenhagen 2
Hong Kong 2
Mahwah 2
Milan 2
New York 2
San Diego 2
Warsaw 2
Wuhan 2
Ballabio 1
Boardman 1
Calvisano 1
Chengdu 1
Chiswick 1
Düsseldorf 1
Eboli 1
Groningen 1
Hebei 1
Helsinki 1
Ilsan 1
Kunming 1
Niagara Falls 1
Nuremberg 1
Pittsburgh 1
Pottstown 1
Ramallah 1
Randers 1
Riverton 1
Shanghai 1
Somerville 1
Swansea 1
Toronto 1
Tukwila 1
Washington 1
Zhengzhou 1
Ürümqi 1
Totale 534
Nome #
Association between high on-aspirin platelet reactivity and reduced superoxide dismutase activity in patients affected by type 2 diabetes mellitus or primary hypercholesterolemia 108
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation 106
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia 94
Effects of PCSK9 inhibitors on platelet function in adults with hypercholesterolemia 83
Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin 64
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus 58
Resistenza agli effetti del GLP-1 sulla risposta pastrinica nel diabete di tipo 2 56
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus 56
In type 2 diabetes mellitus the GLP-1 effects on platelets are impaired. 50
Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up 41
Aberrant Platelet Aggregation as Initial Presentation of Essential Thrombocythemia: Failure of Entero-Coated Aspirin to Reduce Platelet Hyperactivation 3
Totale 719
Categoria #
all - tutte 2.572
article - articoli 0
book - libri 0
conference - conferenze 1.102
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 1 8 2 27 11 14 12 6 10 3
2020/2021135 13 6 15 7 16 15 5 6 16 11 8 17
2021/202294 7 3 1 15 2 3 2 4 2 5 24 26
2022/2023180 17 16 10 19 23 51 13 4 15 4 4 4
2023/202460 1 13 5 5 6 7 2 1 0 6 5 9
2024/202521 2 19 0 0 0 0 0 0 0 0 0 0
Totale 719